← Leaderboards
Kirk B Lane
Generx+, Inc.
$856,143
Attributed
$856,143
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$856,143 · 2
By mechanism
R42$749,143 · 1
R41$107,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationRespiratory Disorder ChemotherapyPleural Cavity EffusionTherapy Design /DevelopmentTransforming Growth FactorsX RayDrug Adverse EffectLaboratory RabbitBleomycinPainPatient Oriented ResearchPleural CavityRespiratory PharmacologySheepNeoplastic GrowthBlood ChemistryCancer ComplicationClinical ResearchComputed Axial TomographyHuman SubjectHuman Therapy Evaluation